214 related articles for article (PubMed ID: 38125359)
1. Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Quan Q; Ma X; Li M; Li X; Yuan H
Exp Ther Med; 2024 Jan; 27(1):31. PubMed ID: 38125359
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone Reduces β Amyloid Levels
Quan Q; Qian Y; Li X; Li M
Front Aging Neurosci; 2019; 11():178. PubMed ID: 31379559
[TBL] [Abstract][Full Text] [Related]
5. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 improved learning and memory ability and reduces neuronal apoptosis in epileptic rats through ERK/CREB/BDNF signal pathway.
Zhang J; Zhu C; Jin Y; Shen W; Pan Y; Shen Y
Biochem Biophys Res Commun; 2023 Oct; 675():26-32. PubMed ID: 37451214
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 protects against neurodegeneration by inducing neurite outgrowth in cultured hippocampal neurons.
Huang L; Liu LF; Liu J; Dou L; Wang GY; Liu XQ; Yuan QL
Neural Regen Res; 2016 Feb; 11(2):319-25. PubMed ID: 27073387
[TBL] [Abstract][Full Text] [Related]
10. [Ginsenoside-Rg1 inhibits cell apoptosis induced by beta amyloid].
Wei CB; Jia JP; Liang P; Guan YQ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(25):1763-6. PubMed ID: 19035088
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells.
Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W
Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193
[TBL] [Abstract][Full Text] [Related]
12. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein.
Gong L; Li SL; Li H; Zhang L
Pharm Biol; 2011 May; 49(5):501-7. PubMed ID: 21438847
[TBL] [Abstract][Full Text] [Related]
14. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway.
Wu J; Pan Z; Wang Z; Zhu W; Shen Y; Cui R; Lin J; Yu H; Wang Q; Qian J; Yu Y; Zhu D; Lou Y
Neuropharmacology; 2012 Sep; 63(3):349-61. PubMed ID: 22534050
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.
Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H
Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087
[TBL] [Abstract][Full Text] [Related]
17. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease.
Mu JS; Lin H; Ye JX; Lin M; Cui XP
Mol Med Rep; 2015 Sep; 12(3):3862-3868. PubMed ID: 26016457
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice.
Zhang H; Su Y; Sun Z; Chen M; Han Y; Li Y; Dong X; Ding S; Fang Z; Li W; Li W
J Ginseng Res; 2021 Nov; 45(6):665-675. PubMed ID: 34764721
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.
Lau WS; Chen WF; Chan RY; Guo DA; Wong MS
Br J Pharmacol; 2009 Apr; 156(7):1136-46. PubMed ID: 19298253
[TBL] [Abstract][Full Text] [Related]
20. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]